Gastroenterology

People with IBD have a shorter life expectancy
Asthma, eczema and food sensitivity are risk factors for IBS, study finds
Is chocolate safe for people with IBS?
Low FODMAP diet reduces epithelial injury in IBS patients
Health Canada examines safety of inflammatory bowel disease drug mesalazine in pregnancy

Safety review could not confirm a link between the use of mesalazine (5-ASA) during pregnancy and birth defects in babies.
Fibristal voluntarily withdrawn in Canada due to risk of serious liver injury

Allergan withdraws and recalls uterine fibroid drug ulipristal acetate in Canada due to rare cases of severe liver injury requiring liver transplantation
Using PPIs may increase risk of contracting COVID-19: study

Previous research has demonstrated that a low level of gastric acid alters the infectivity of SARS-CoV-1—that also appears to be the case for SARS-CoV-2
Lynch syndrome: evidence mounting for ASA prophylaxis, but uncertainties remain

Longer-term results of CAPP2 study support use of ASA for prevention of colorectal cancer in patients with Lynch syndrome

Eluxadoline and rifaximin show promise for IBS-D treatment: review